THOMAS G. WIGGANS - 02 Mar 2022 Form 4 Insider Report for PARDES BIOSCIENCES, INC.

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Issuer symbol
N/A
Transactions as of
02 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Mar 2022, 15:40:26 UTC
Previous filing
04 Mar 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRDS Stock Option (Right to Buy) Award $0 +985,000 $0.000000 985,000 02 Mar 2022 Common Stock 985,000 $6.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to such option vest and become exercisable on the first anniversary of March 1, 2022 and the remaining 3/4th of the shares subject to such option will vest and become exercisable in substantially equal monthly installments on the 1st day of each month thereafter, subject to a continued service relationship.